133 related articles for article (PubMed ID: 10531190)
1. Apples and oranges : flaws and guffaws.
Petty TL
Chest; 1999 Oct; 116(4):1137-8. PubMed ID: 10531190
[No Abstract] [Full Text] [Related]
2. Efficacy of salmeterol xinafoate in the treatment of COPD.
Mahler DA; Donohue JF; Barbee RA; Goldman MD; Gross NJ; Wisniewski ME; Yancey SW; Zakes BA; Rickard KA; Anderson WH
Chest; 1999 Apr; 115(4):957-65. PubMed ID: 10208192
[TBL] [Abstract][Full Text] [Related]
3. Inhaled oxitropium bromide is currently used as the first-line therapy of patients with chronic pulmonary disease in Japan.
Teramoto S; Ouchi Y
Eur Respir J; 1999 Feb; 13(2):473-5. PubMed ID: 10065703
[No Abstract] [Full Text] [Related]
4. A week-long course of inhaled beta-agonist or anticholinergic agent may reduce dyspnea during exercise in COPD.
Teramoto S; Fukuchi Y; Ouchi Y
Chest; 1996 Jun; 109(6):1666-7. PubMed ID: 8769538
[No Abstract] [Full Text] [Related]
5. Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD.
Ikeda A; Nishimura K; Izumi T
Chest; 1996 Jan; 109(1):294. PubMed ID: 8549208
[No Abstract] [Full Text] [Related]
6. Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD.
Ingram RH
Chest; 1996 Jan; 109(1):293. PubMed ID: 8549206
[No Abstract] [Full Text] [Related]
7. [Clinical aspects of anticholinergic agents].
Friedman M
Rev Mal Respir; 1998 Sep; 15 Suppl 2():S51-4. PubMed ID: 9809345
[No Abstract] [Full Text] [Related]
8. Does high dose ipratropium bromide added to salbutamol improve pulmonary function for patients with chronic obstructive airways disease in the emergency department?
Koutsogiannis Z; Kelly AM
Aust N Z J Med; 2000 Feb; 30(1):38-40. PubMed ID: 10800876
[TBL] [Abstract][Full Text] [Related]
9. A combination with clinical recommended dosages of salmeterol and ipratropium is not more effective than salmeterol alone in patients with chronic obstructive pulmonary disease.
Matera MG; Caputi M; Cazzola M
Respir Med; 1996 Sep; 90(8):497-9. PubMed ID: 8869445
[No Abstract] [Full Text] [Related]
10. Anticholinergic bronchodilators.
Witek TJ
Respir Care Clin N Am; 1999 Dec; 5(4):521-36. PubMed ID: 10565879
[TBL] [Abstract][Full Text] [Related]
11. Salmeterol xinafoate in asthma.
Palmer JB; Oxford JM
JAMA; 1994 Nov 23-30; 272(20):1575-6. PubMed ID: 7966861
[No Abstract] [Full Text] [Related]
12. [Treatment of COPD in primary care].
Golpe Gómez R; Mateos Colino A
Arch Bronconeumol; 2000 Mar; 36(3):167. PubMed ID: 10782272
[No Abstract] [Full Text] [Related]
13. Treatment persistence and compliance with medications for chronic obstructive pulmonary disease.
Cramer JA; Bradley-Kennedy C; Scalera A
Can Respir J; 2007; 14(1):25-9. PubMed ID: 17315055
[TBL] [Abstract][Full Text] [Related]
14. Use of a long-acting inhaled beta2-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary disease.
Rennard SI; Anderson W; ZuWallack R; Broughton J; Bailey W; Friedman M; Wisniewski M; Rickard K
Am J Respir Crit Care Med; 2001 Apr; 163(5):1087-92. PubMed ID: 11316640
[TBL] [Abstract][Full Text] [Related]
15. [Bronchodilator treatment of COPD].
Naberan K
Aten Primaria; 1998 Feb; 21(2):109-13. PubMed ID: 9608136
[No Abstract] [Full Text] [Related]
16. The addition of salmeterol 50 microg bid to anticholinergic treatment in patients with COPD: a randomized, placebo controlled trial. Chronic obstructive pulmonary disease.
Chapman KR; Arvidsson P; Chuchalin AG; Dhillon DP; Faurschou P; Goldstein RS; Kuipers AF;
Can Respir J; 2002; 9(3):178-85. PubMed ID: 12068339
[TBL] [Abstract][Full Text] [Related]
17. Relative and additional bronchodilator response of salbutamol and ipratropium in smoker and nonsmoker asthmatics.
Ahmad Z; Singh SK
J Asthma; 2010 Apr; 47(3):340-3. PubMed ID: 20394521
[TBL] [Abstract][Full Text] [Related]
18. Additive effects of salmeterol and fluticasone or theophylline in COPD.
Cazzola M; Di Lorenzo G; Di Perna F; Calderaro F; Testi R; Centanni S
Chest; 2000 Dec; 118(6):1576-81. PubMed ID: 11115442
[TBL] [Abstract][Full Text] [Related]
19. Inhaled salmeterol: a review of its efficacy in chronic obstructive pulmonary disease.
Jarvis B; Markham A
Drugs Aging; 2001; 18(6):441-72. PubMed ID: 11419918
[TBL] [Abstract][Full Text] [Related]
20. Asthma exacerbations and formoterol.
Rissmiller RW; Larj MJ; Peters SP; Bleecker ER
Chest; 2004 Apr; 125(4):1590-1. PubMed ID: 15078782
[No Abstract] [Full Text] [Related]
[Next] [New Search]